Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    "pantothenate kinase-associated neurodegeneration" OR "Hallervorden-Spatz Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"pantothenate kinase-associated neurodegeneration" OR "Hallervorden-Spatz Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Placebo oral solution
2 Active, not recruiting Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Deferiprone
3 Recruiting Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-associated Neurodegeneration (PKAN)
Intervention:
4 Available Compassionate Use of Deferiprone in Patients With PKAN
Condition: Pantothenate Kinase-Associated Neurodegeneration
Intervention: Drug: Deferiprone
5 Recruiting Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Patients
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: fosmetpantotenate (RE-024);   Drug: Placebo
6 Recruiting NBIAready: Online Collection of Natural History Patient-reported Outcome Measures
Condition: Neurodegeneration With Brain Iron Accumulation (NBIA)
Intervention:
7 Active, not recruiting Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
Conditions: Neurodegenerative Disease;   Iron Overload
Intervention: Drug: Deferiprone

Study has passed its completion date and status has not been verified in more than two years.